Answers are grounded in this paper and cite their sources.
Nationwide cohort study demonstrates progressive reductions in infection, hospitalization, and death following initial COVID-19 vaccination, highlighting robust real-world vaccine effectiveness.
To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% CI: 0.04-0.11) reductions 36-42 days post-first dose. Our results support ongoing vaccination campaigns.
No takes yet. Share an insight, caveat, or question.
Mateo‐Urdiales et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: